Home
Scholarly Works
Cardio protection with dulaglutide is not...
Conference

Cardio protection with dulaglutide is not depending on baseline therapy with metformin: a subgroup analysis of the REWIND trial

Authors

Ferrannini G; Gerstein HC; Colhoun HM; Dagenais GR; Diaz R; Dyal L; Lakshmanan M; Mellbin L; Probstfield J; Riddle MC

Volume

63

Pagination

pp. S282-S282

Publisher

SPRINGER

Publication Date

September 1, 2020

Name of conference

56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)

Conference place

ELECTR NETWORK

Conference start date

September 21, 2020

Conference end date

September 25, 2020

Conference proceedings

DIABETOLOGIA

Issue

SUPPL 1

ISSN

0012-186X

Labels

Contact the Experts team